IL225300A - Cyclosporin emulsion - Google Patents

Cyclosporin emulsion

Info

Publication number
IL225300A
IL225300A IL225300A IL22530013A IL225300A IL 225300 A IL225300 A IL 225300A IL 225300 A IL225300 A IL 225300A IL 22530013 A IL22530013 A IL 22530013A IL 225300 A IL225300 A IL 225300A
Authority
IL
Israel
Prior art keywords
cyclosporine
concentration
sandimmune
study
oil
Prior art date
Application number
IL225300A
Other languages
English (en)
Hebrew (he)
Other versions
IL225300A0 (en
Original Assignee
Neurovive Pharmaceutical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43733181&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL225300(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurovive Pharmaceutical Ab filed Critical Neurovive Pharmaceutical Ab
Publication of IL225300A0 publication Critical patent/IL225300A0/en
Publication of IL225300A publication Critical patent/IL225300A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
IL225300A 2010-10-01 2013-03-18 Cyclosporin emulsion IL225300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38863310P 2010-10-01 2010-10-01
DKPA201000891 2010-10-01
PCT/EP2011/067117 WO2012042023A2 (en) 2010-10-01 2011-09-30 Cyclosporine emulsion

Publications (2)

Publication Number Publication Date
IL225300A0 IL225300A0 (en) 2013-06-27
IL225300A true IL225300A (en) 2017-06-29

Family

ID=43733181

Family Applications (1)

Application Number Title Priority Date Filing Date
IL225300A IL225300A (en) 2010-10-01 2013-03-18 Cyclosporin emulsion

Country Status (15)

Country Link
US (2) US9040487B2 (ru)
EP (1) EP2621469B1 (ru)
JP (1) JP5860468B2 (ru)
KR (1) KR101801430B1 (ru)
CN (2) CN103118664B (ru)
AU (1) AU2011310111B9 (ru)
CA (1) CA2812901C (ru)
CL (1) CL2013000865A1 (ru)
EA (1) EA027081B1 (ru)
ES (1) ES2597959T3 (ru)
HK (1) HK1208357A1 (ru)
IL (1) IL225300A (ru)
MX (2) MX340897B (ru)
PL (1) PL2621469T3 (ru)
WO (1) WO2012042023A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2690428B1 (en) * 2011-03-23 2019-11-13 Terumo Kabushiki Kaisha Component measurement device
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
KR101211902B1 (ko) * 2012-04-30 2012-12-13 주식회사 휴온스 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
US10251837B2 (en) * 2014-02-14 2019-04-09 Jingjun Huang Compositions for nanoemulsion delivery systems
CN104055749B (zh) * 2014-05-27 2017-05-24 无锡曙辉药业有限公司 环孢素a的自微乳化软胶囊内容物组合及其制备方法
CN105267144B (zh) * 2014-07-04 2020-08-18 四川科伦药业股份有限公司 一种环孢素脂肪乳注射液
US20190038555A1 (en) * 2016-02-26 2019-02-07 The Regents Of The University Of California Bicontinuous microemulsions and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900004323A (ko) * 1988-09-29 1990-04-12 후쿠하라 요시하루 유화 조성물
EP0570829B1 (de) * 1992-05-18 2001-04-25 CicloMulsion AG Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur intravenösen Applikation sowie Verfahren zu ihrer Herstellung
JP3200639B2 (ja) 1992-05-19 2001-08-20 カシオ計算機株式会社 薄膜トランジスタパネルの製造方法
US5660858A (en) 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
DE19961733A1 (de) * 1999-12-21 2001-06-28 Ciclomulsion Ag Cyclosporin(e) enthaltende hypertone pharmazeutische Zubereitung zur Anwendung bei neurologischen Erkrankungen und als Neuroprotektivum sowie Verfahren zu ihrer Herstellung
JP5008571B2 (ja) * 2004-11-09 2012-08-22 ノバガリ ファルマ エスア 免疫抑制剤を含む眼科用エマルジョン
CN101904814A (zh) * 2009-06-04 2010-12-08 上海恒瑞医药有限公司 制备载药乳剂的方法

Also Published As

Publication number Publication date
EA201390507A1 (ru) 2013-08-30
MX336100B (es) 2016-01-08
KR20130124944A (ko) 2013-11-15
AU2011310111B2 (en) 2014-08-14
ES2597959T3 (es) 2017-01-24
JP5860468B2 (ja) 2016-02-16
AU2011310111C9 (en) 2016-11-24
CN104548064A (zh) 2015-04-29
WO2012042023A2 (en) 2012-04-05
EP2621469B1 (en) 2016-07-20
US20130323270A1 (en) 2013-12-05
CA2812901C (en) 2019-02-19
AU2011310111C1 (en) 2015-05-07
US20150238563A1 (en) 2015-08-27
PL2621469T3 (pl) 2017-01-31
CL2013000865A1 (es) 2014-03-28
US9040487B2 (en) 2015-05-26
CN103118664B (zh) 2015-11-25
AU2011310111B9 (en) 2016-11-24
MX340897B (es) 2016-07-29
HK1208357A1 (en) 2016-03-04
CA2812901A1 (en) 2012-04-05
JP2013538843A (ja) 2013-10-17
IL225300A0 (en) 2013-06-27
WO2012042023A3 (en) 2012-06-21
KR101801430B1 (ko) 2017-11-24
EP2621469A2 (en) 2013-08-07
MX2013003578A (es) 2013-10-25
AU2011310111A1 (en) 2013-04-04
CN103118664A (zh) 2013-05-22
EA027081B1 (ru) 2017-06-30

Similar Documents

Publication Publication Date Title
US20150238563A1 (en) Cyclosporine emulsion
DE4340781C3 (de) Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
US20050027019A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
CN109922811B (zh) 包含至少一种氧化胆固醇硫酸酯以及聚亚烷基二醇、羧甲基纤维素和聚氧乙烯甘油酯中的至少一种的组合物及其使用方法
NO175287B (no) Fremgangsmåte for fremstilling av et intravenöst, farmasöytisk preparat
CN109069651A (zh) 稳定的尼莫地平肠胃外制剂
Ehinger et al. Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor® EL
JP2001515491A (ja) 親油性化合物の投与のための親油性二成分系
HUE027298T2 (en) Pharmaceutical composition containing developed storage and dissolution properties containing 3-beta-hydroxy-5-alpha-pregnan-20-one
CN107205920A (zh) 可注射丁丙诺啡制剂
JP2018515484A (ja) カバジタキセル脂肪乳剤注射剤、その調製方法およびその使用
CN1708270A (zh) 丙泊酚与半胱氨酸
US20230364030A1 (en) Parenteral treatments involving aminoadamantane derivatives
CN101439018A (zh) 一种静脉注射用水飞蓟宾类化合物乳剂及其制备方法
CN115990262A (zh) 不含乙醇和磷脂的湿热灭菌的尼莫地平组合物及其制备方法
BR112013007373B1 (pt) Emulsão de ciclosporina, e, uso de uma emulsão de ciclosporina
CN104274406B (zh) 一种注射用他克莫司脂肪乳剂及其制备方法
JP2022514991A (ja) 安定な麻酔薬製剤および関連する剤形
WO2019094819A2 (en) Intravenous delivery systems for chemotherapy drugs
JP2002533401A (ja) シクロスポリン溶液
US20220175878A1 (en) Method for preparing eye drops of cyclosporin a
CA3151010A1 (en) Rifaximin liquid formulations
Zankar et al. Allergie à la cyclosporine intraveineuse

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed